Literature DB >> 26339416

Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones.

Yue-Hu Han1, Bo Gao1, Jing-Hui Huang1, Zhen Wang1, Zheng Guo1, Qiang Jie1, Liu Yang1, Zhuo-Jing Luo1.   

Abstract

BACKGROUND: Giant cell tumor of bone (GCT) is a potentially malignant tumor. CD147 is a multifunctional protein, which expresses itself in many tumors. In this study, we have investigated the correlation between CD147 and PCNA, VEGF, MMPs expression in giant cell tumor of bones. We have also explored the relationship between its clinical pathology and prognosis.
RESULTS: A significant difference of the expression level of CD147, MMPs was found in cases of GCT with Jaffe grading and prognosis (P<0.05). But, it was not in accordance with the patient's age and sex. An expression of CD147 was positively correlated with MMP-9, VEGF, MVD, PCNA (r=0.271, P=0.025; r=0.411, P=0.000; r=0.872, P=0.000; r=0.394, P=0.001).
CONCLUSION: The expression level of CD147 in giant cell tumors of bones is correlated with the development of cancers and relapse. There was a positive correlation between expressions of CD147 and MMP-9, VEGF, MVD, PCNA, and CD147. This is an important indicator in evaluating the malignant degree and prognosis of giant cell tumors of bone. It may be the new target for ensuring chemopreventive strategies.

Entities:  

Keywords:  EMMPRIN; Giant cell tumor of bone; MMP; extracellular matrix metalloproteinases inducer; immunohistochemistry; matrix metalloproteinases; vascular endothelial growth factor

Mesh:

Substances:

Year:  2015        PMID: 26339416      PMCID: PMC4555744     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

Review 1.  Matrix metalloproteinases in tumor invasion and metastasis.

Authors:  I Stamenkovic
Journal:  Semin Cancer Biol       Date:  2000-12       Impact factor: 15.707

2.  Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts.

Authors:  Takuro Kanekura; Xiang Chen; Tamotsu Kanzaki
Journal:  Int J Cancer       Date:  2002-06-01       Impact factor: 7.396

3.  MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

Authors:  L M Coussens; C L Tinkle; D Hanahan; Z Werb
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

Review 4.  The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.

Authors:  A John; G Tuszynski
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 5.  Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

Authors:  Pia Vihinen; Veli-Matti Kähäri
Journal:  Int J Cancer       Date:  2002-05-10       Impact factor: 7.396

6.  Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk.

Authors:  A R M Ruhul Amin; Takeshi Senga; Myat Lin Oo; Aye Aye Thant; Michinari Hamaguchi
Journal:  Genes Cells       Date:  2003-06       Impact factor: 1.891

7.  Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.

Authors:  Kazuki Nabeshima; Junji Suzumiya; Mitsuyuki Nagano; Koichi Ohshima; Bryan P Toole; Kazuo Tamura; Hiroshi Iwasaki; Masahiro Kikuchi
Journal:  J Pathol       Date:  2004-03       Impact factor: 7.996

8.  Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer.

Authors:  G I Murray; M E Duncan; P O'Neil; W T Melvin; J E Fothergill
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

9.  Expression pattern of matrix metalloproteinases in human liver.

Authors:  R Lichtinghagen; T Helmbrecht; B Arndt; K H Böker
Journal:  Eur J Clin Chem Clin Biochem       Date:  1995-02

Review 10.  Role of cancer cell-stroma interaction in invasive growth of cancer cells.

Authors:  Hiroaki Kataoka; Hiroyuki Tanaka; Koki Nagaike; Shuichiro Uchiyama; Hiroshi Itoh
Journal:  Hum Cell       Date:  2003-03       Impact factor: 4.374

View more
  6 in total

1.  Up-regulation of matrix metalloproteinase-9 in primary bone tumors and its association with tumor aggressiveness.

Authors:  Mohammad Amin Vaezi; Amir Reza Eghtedari; Banafsheh Safizadeh; Ghasem Ghasempour; Vahid Salimi; Mitra Nourbakhsh; Shima Nazem; Masoumeh Tavakoli-Yaraki
Journal:  Mol Biol Rep       Date:  2022-08-24       Impact factor: 2.742

2.  A Multiparametric Method Based on Clinical and CT-Based Radiomics to Predict the Expression of p53 and VEGF in Patients With Spinal Giant Cell Tumor of Bone.

Authors:  Qizheng Wang; Yang Zhang; Enlong Zhang; Xiaoying Xing; Yongye Chen; Ke Nie; Huishu Yuan; Min-Ying Su; Ning Lang
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

3.  Integrative analysis of BSG expression in NPC through immunohistochemistry and public high-throughput gene expression data.

Authors:  Li Gao; Jin-Cai Zhong; Wen-Ting Huang; Yi-Wu Dang; Min Kang; Gang Chen
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

4.  Involvement of RBP4 in all‑trans retinoic acid induced cleft palate.

Authors:  Shiyi Dong; Yadong Zhang; Hongzhang Huang
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

5.  Histochemical and Immunohistochemical Study of α-SMA, Collagen, and PCNA in Epithelial Ovarian Neoplasm

Authors:  Nungki Anggorowati; Chatarina Ratna Kurniasari; Karina Damayanti; Titik Cahyanti; Irianiwati Widodo; Ahmad Ghozali; Muhammad Mansyur Romi; Dwi Cahyani Ratna Sari; Nur Arfian
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

6.  The role of a drug-loaded poly (lactic co-glycolic acid) (PLGA) copolymer stent in the treatment of ovarian cancer.

Authors:  Yanqing Wang; Xiaoyin Qiao; Xiao Yang; Mengqin Yuan; Shu Xian; Li Zhang; Dongyong Yang; Shiyi Liu; Fangfang Dai; Zhikai Tan; Yanxiang Cheng
Journal:  Cancer Biol Med       Date:  2020-02-15       Impact factor: 4.248

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.